Elthera is a privately held company located in Schlieren, Switzerland. We have secured CHF 5.2 Mio Seed funding from individual and institutional investors. If you want to learn more about investing in Elthera please contact us.

Please send enquiries to: .


Università della Svizzera italiana, Institute of Oncology Research, Bellinzona, Switzerland.
Elthera is working with Dr. Francesco Bertoni from the group of Lymphoma Genomics. The work is funded by an Innosuisse grant.

University Hospital Schleswig Holstein, Kiel, Germany
Elthera is collaborating with Prof Susanne Sebens from the Institute of Experimental Cancer Research on fundamental aspects of the role of L1CAM in cancer progression.

Targos GmbH, Kassel, Germany
Elthera is collaborating with with Targos GmbH on the development on a solid biopsy-based companion diagnostic for anti-L1CAM therapy.

iCellate Medical AB, Solna, Sweden
Elthera is working with iCellate Medical AB to develop novel L1CAM-based liquid biopsy methods to support patient selection and treatment monitoring in clinical trials.